A celebrity's recent multiple sclerosis misdiagnosis highlights the complexities of medical liability and the error in judgment defense.
Real-world data show mortality, kidney, and cardiovascular benefits even among those with frailty and multimorbidity.
Ursodeoxycholic acid recommended as first-line therapy and to prevent recurrence after liver transplant for PBC.
The oral selective ROCK2 inhibitor aims to restore frataxin protein expression and will be evaluated in a 12-week phase 2a dose-ranging trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results